{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-25-000774","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.760147+00:00","generated_at":"2026-05-22T05:11:23.034134+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"confidence":"high","headline":"TOI shareholders approve reverse stock split up to 1:40; re-elect all 8 directors","bullets":["Reverse stock split approved at ratio between 1:5 and 1:40, board discretion within one year.","All eight director nominees elected; Richard Barasch received 39.2M votes for, 654k withheld.","Ratification of BDO USA as auditor for FY2025 approved with 61.2M for, 682k against.","Turnout of 61.9M shares representing 81.7% of outstanding common stock."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-25-000774","json":"https://secwatch.observer/filing/0001079973-25-000774.json","markdown":"https://secwatch.observer/filing/0001079973-25-000774.md","text":"https://secwatch.observer/filing/0001079973-25-000774.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/0001079973-25-000774-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000774/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T05:11:23.034134+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}